Article
From Histology to Multi-Omics: Review of Chordoma Classification and Its Clinical Implications
2026-04-03
Abstract excerpt
Chordoma is a rare malignant neoplasm of the axial skeleton, arising from notochordal remnants. No approved systemic therapies exist and a 10-year overall survival is below 60%. Accurate molecular and pathological classification is a prerequisite for improved prognostication and identification of actionable therapeutic targets, yet molecular classification of chordoma remains significantly less advanced than in ot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9ac5e1cb-16ec-52a3-8baa-7baf8ff75b2d
- DOI
- 10.20944/preprints202604.0289.v1
